Trust Point Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
5,049
-3,717
-42% -$202K 0.02% 435
2026
Q1
$550K Sell
8,766
-63
-0.7% -$5.04K 0.05% 226
2025
Q4
$842K Buy
8,829
+338
+4% +$33.1K 0.07% 143
2025
Q3
$829K Buy
8,491
+582
+7% +$60.3K 0.07% 145
2025
Q2
$850K Buy
7,909
+954
+14% +$96.5K 0.08% 122
2025
Q1
$702K Sell
6,955
-3,340
-32% -$336K 0.06% 167
2024
Q4
$920K Sell
10,295
-253
-2% -$22.3K 0.06% 172
2024
Q3
$884K Sell
10,548
-140
-1% -$11K 0.07% 183
2024
Q2
$823K Sell
10,688
-748
-7% -$54.8K 0.07% 185
2024
Q1
$783K Sell
11,436
-6,984
-38% -$449K 0.06% 199
2023
Q4
$1.06M Buy
+18,420
New +$983K 0.09% 124

Other funds holding BSX

Trust Point Inc's BSX Position: Q2 2026 in Review

Trust Point Inc reduced its Boston Scientific (BSX) stake by 42% in Q2 2026, selling an estimated $202K and leaving 5,049 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #435.

Trust Point Inc first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.06M in Q4 2023. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Trust Point Inc held 5,049 shares of Boston Scientific worth $215K as of Q2 2026.
  • Trust Point Inc sold 3,717 Boston Scientific shares in Q2 2026, an estimated $202K.
  • Boston Scientific made up 0.02% of Trust Point Inc's portfolio in Q2 2026, its #435 holding.
  • Trust Point Inc first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Boston Scientific position peaked at $1.06M in Q4 2023.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.